For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Cincinnati, Ohio 45267

0 studies enrolling now · 65 studies all time

What they study most

Acute Coronary Syndrome, Advanced Non-Small Cell Lung Cancer, Alcohol Dependence, Anxiety Neuroses, Anxiety States, Neurotic, Attention Deficit Hyperactivity Disorder, Autoimmune Disease, Benign Prostatic Hyperplasia, Bipolar Disorder, Cardiovascular Diseases, Colorectal Cancer, Connective Tissue Disease

Studies at this site

• Study of Participants With Advanced Non-Small Cell Lung Cancer — Completed
• A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only — Completed
• A Study for Adolescents With Fibromyalgia Syndrome — Withdrawn before enrolling
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study for the Treatment of Alcohol Dependence — Completed
• A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer — Completed
• A Study of LY3015014 in Participants With High Cholesterol — Completed
• A Study of LY2523355 in Participants With Breast Cancer — Completed
• A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma — Completed
• A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma — Stopped early
• A Study in Men With Benign Prostatic Hyperplasia — Stopped early
• A Study of LY3025876 in Participants With Diabetes — Completed
• A Study of Enzastaurin in Participants With Follicular Lymphoma — Completed
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Study in Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor — Completed
• A Rheumatoid Arthritis Study in Participants — Completed
• A Study in Prevention of Re-emergence of Depression Symptoms — Completed
• A Study in Patients With Type 2 Diabetes Mellitus — Completed
• A Study of LY2405319 in Participants With Type 2 Diabetes — Completed
• Reduction in the Occurrence of Center-Involved Diabetic Macular Edema — Completed
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer — Completed
• Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome — Completed
• A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer — Completed
• A Study in Participants With Type 2 Diabetes Mellitus — Completed
• Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency — Completed
• Open-Label Phase III Long-Term Safety Trial of Liprotamase — Completed
• Phase III ALTU-135 CP Safety Trial — Stopped early
• Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency — Completed
• A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer — Completed
• A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer — Completed
• A Study in Pediatric Participants With Generalized Anxiety Disorder — Completed
• A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease — Completed
• A Study of Duloxetine in Elderly Generalized Anxiety Disorder — Completed
• A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma — Withdrawn before enrolling
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed
• A Long-Term, Open-Label, Study on Schizophrenia — Stopped early
• Fibromyalgia Health Outcome Study on Cost of Treatments — Completed
• Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease — Completed
• Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer — Completed
• A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis — Completed
• Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease — Completed
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder — Completed
• An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia — Completed
• Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia — Completed